Cerevel Therapeutics Holdings, Inc. (CERE) has an overall financial health rating of C- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2024-07-31.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2024-07-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-30 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-24 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-22 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-19 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-17 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2024-07-16 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
